These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 36615218)
21. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches. Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746 [TBL] [Abstract][Full Text] [Related]
22. Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease. Bowroju SK; Penthala NR; Lakkaniga NR; Balasubramaniam M; Ayyadevara S; Shmookler Reis RJ; Crooks PA Bioorg Med Chem; 2021 Sep; 45():116311. PubMed ID: 34304133 [TBL] [Abstract][Full Text] [Related]
23. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors. Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888 [TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors. Mehrazar M; Hassankalhori M; Toolabi M; Goli F; Moghimi S; Nadri H; Bukhari SNA; Firoozpour L; Foroumadi A Mol Divers; 2020 Nov; 24(4):997-1013. PubMed ID: 31845210 [TBL] [Abstract][Full Text] [Related]
25. N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity. Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alan E; Sevin G; Erciyas E; Holzgrabe U; Alptuzun V Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200519. PubMed ID: 36461719 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. Khoobi M; Alipour M; Sakhteman A; Nadri H; Moradi A; Ghandi M; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2013 Oct; 68():260-9. PubMed ID: 23988409 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors. Qiu GL; He SS; Chen SC; Li B; Wu HH; Zhang J; Tang WJ J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1506-1515. PubMed ID: 30284486 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors. Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207 [TBL] [Abstract][Full Text] [Related]
30. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives. Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344 [TBL] [Abstract][Full Text] [Related]
31. Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents. Saeedi M; Felegari P; Iraji A; Hariri R; Rastegari A; Mirfazli SS; Edraki N; Firuzi O; Mahdavi M; Akbarzadeh T Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000258. PubMed ID: 33226157 [TBL] [Abstract][Full Text] [Related]
32. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease. Kumar V; Saha A; Roy K Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088 [TBL] [Abstract][Full Text] [Related]
33. Search for new multi-target compounds against Alzheimer's disease among histamine H Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities. Işık A; Acar Çevik U; Karayel A; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA SAR QSAR Environ Res; 2022 Mar; 33(3):193-214. PubMed ID: 35243936 [TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949 [TBL] [Abstract][Full Text] [Related]
36. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease. Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948 [TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of ligustrazine derivatives as potential anti-Alzheimer's agents. Chen XF; Li SS; Bai YJ; Zhao ZF; Bai YJ; Gong G; He XR; Zheng XH Nat Prod Res; 2024 Aug; 38(16):2825-2835. PubMed ID: 37505222 [TBL] [Abstract][Full Text] [Related]
38. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment. Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176 [TBL] [Abstract][Full Text] [Related]
39. Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors. Krátký M; Štěpánková Š; Brablíková M; Svrčková K; Švarcová M; Vinšová J Curr Top Med Chem; 2020; 20(23):2106-2117. PubMed ID: 32814531 [TBL] [Abstract][Full Text] [Related]
40. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group. Gao XH; Zhou C; Liu HR; Liu LB; Tang JJ; Xia XH J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]